monalisa sahu

Dr. monalisa sahu


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

16 July 2023 in World Journal of Otorhinolaryngology - Head and Neck Surgery
Verified
Journal Article
Open access
PSPradipt Ranjan Sahoo
Pradipt Ranjan Sahoo
MSmonalisa sahu
monalisa sahu
IKImran Wasfi Khan
Imran Wasfi Khan
KSKabikanta Samantaray
Kabikanta Samantaray
Objective: To evaluate an endoscopic approach in the management of glomus tumor, and also to investigate and evaluate its appropriateness and feasibility.Methods: Glomus tumors, also known as paragangliomas, are benign primary tumors of the middle ear. The advent of endoscopic ear surgery has provided new dimensions to the management of this highly vascular tumor. Retrospective analysis of six patients of glomus tympanicum, operated between July 2014 and June 2019, with modified Fisch classification Type A and B1, who were managed by a retroauricular transcanal endoscopic approach. Preoperative and postoperative analysis was done for these patients.Results: The chief complaint was pulsatile tinnitus, which disappeared in five cases and reduced in severity in one of them. Hearing was improved with reduction in air‐bone gap in all the cases. No major complications or recurrence were observed in any of the patients after 12 months of follow‐up.Conclusion: This endoscopic approach serves as a safe and reliable technique for tumor removal. It thus provides postoperative comfort for most of the patients.

25 March 2021 in New England Journal of Medicine
Verified
Journal Article
Closed access
MSmonalisa sahu
monalisa sahu
PSPradipt R. Sahoo
Pradipt R. Sahoo
A 5-year-old girl presented with fever, sore throat, and pain with swallowing. Examination showed a strawberry tongue. A throat culture grew group A streptococcus.

11 October 2024 in Journal of Clinical and Experimental Hepatology
Verified
Journal Article
Closed access
MSmonalisa sahu
monalisa sahu
DPDibyalochan Praharaj
Dibyalochan Praharaj
ABAjeet S. Bhadoria
Ajeet S. Bhadoria

20 September 2022 in Medical Mycology
Verified
Journal Article
Open access
PDF file
MSmonalisa sahu
monalisa sahu
SCSourabh Chakraborty
Sourabh Chakraborty
GJGeethu Joe
Geethu Joe
RDRahul N. Doshi
Rahul N. Doshi
RSRajeev Soman
Rajeev Soman
Poster session 2, September 22, 2022, 12:30 PM - 1:30 PM Multiple infections can occur after 2009, pandemic influenza, including fungal and bacterial infections, but data from India are limited. To our knowledge, this is the first reported case of influenza-associated invasive pulmonary aspergillosis (IAPA), caused by Aspergillus tamarii, after infection with pandemic (H1N1) 2009 which was preceded by COVID-19, 20 months before. A 33-year-old male, known asthmatic, had been hospitalized elsewhere in August 2020 with COVID-19 pneumonia for 50 days and had been on mechanical ventilation for 37 days. He had no residual respiratory symptoms 3 months after recovery from COVID-19. He was admitted to Jupiter Hospital in April 2022 with fever, cough, and dyspnea for 8 days, which developed after a cold bath in a temple. HRCT (chest) showed ground glass opacities (GGOs), crazy paving, nodules, and traction bronchiectasis. Review of previous HRCT showed that only GGOs were present (Fig. 1). At admission, the nasopharyngeal swab was positive for pandemic (H1N1) 2009 in the filmarray respiratory panel and no other pathogen was detected. He was treated with oseltamivir. Expectorated sputum examination showed a heavy load of thin septate hyphae, with acute angle branching, resembling Aspergilllus species (Fig. 2). Serum galactomannan was positive (1.8). Based on these features he was diagnosed as a case of probable IAPA and initiated posaconazole (PCZ) treatment. Sputum fungal culture was positive and was identified by MALDI TOF MS as A. tamarii. A. tamarii has been rarely encountered as a human pathogen. Case reports of its involvement in eyelid infection, keratitis, invasive sinonasal infection, and onychomycosis exist. Sensititre MICs were 0.0625 mcg/ml, 0.125 mcg/ml, 0.0625 mcg/ml, and 0.125 mcg/mL for itraconazole, voriconazole, PCZ, and for isavuconazole (ISVCZ) respectively. The usually obtained PCZ trough level with standard dose is 1.2 mg/l which generates AUC of 200R. The usually obtained ISVC) trough level with standard dose is 3 mg/l which generates AUC of 100R. The PKPD index, AUC/MIC of 100, is needed with both these azoles for a therapeutic effectR. Therefore, it would be possible to treat this infection with any of these azoles. PCZ was continued in view of the easy availability of therapeutic drug monitoring (TDM) to assure adequate drug exposure, lower cost, and clinical improvement which had already occurred. An infection due to a rare Aspergillus species needs correct identification, MIC determination, and PKPD consideration for appropriate drug selection and management.

1 July 2023 in International Journal of Surgery Open
Verified
Journal Article
Open access
MSmonalisa sahu
monalisa sahu
AMAroop Mohanty
Aroop Mohanty
SSSanjit Sah
Sanjit Sah
Ranjit SahRanjit Sah
Ranjit Sah